Autoimmunity may contribute to retinal degeneration. The studies examined the evolution of autoimmune responses against retina in naïve dystrophic RCS rats over the course of retinal degeneration. We showed that anti-retinal autoantibodies and T cells are generated in response to the availability of antigenic material released from dying photoreceptor cells during retinal degeneration but with distinctive activation trends. Passive transfer of anti-retinal antibodies enhanced disease progression by disrupting the BRB, upregulating MCP-1, attracting blood macrophages into retina, and augmenting apoptotic photoreceptor cell death. Our findings directly link anti-retinal autoantibodies to activated macrophage entry and their possible role in neurodegeneration.
Introduction
One common feature for retinitis pigmentosa (RP), age-related retinal degeneration (AMD), autoimmune retinopathy (AR), and related diseases is retinal degeneration that leads to incurable blindness. The mechanism involved in development of those various retinopathies is not completely understood, but it appears to be caused by a combination of factors, including inflammatory and autoimmune factors. While typical retinal degenerations are not classical inflammatory diseases, recent findings support the concept that the immune/autoimmune mechanisms may play an important role in the degenerative process (Penfold et al., 2001; Donoso et al., 2006; Adamus, 2009; Morohoshi et al., 2009; Anderson et al., 2010) . The most common finding is the presence of serum anti-retinal autoantibodies (AAbs), associated with a number of retinal diseases, including paraneoplastic retinopathies (Adamus, 2009). Notably, AAbs persist over the progression of retinal degenerative and their levels can be fluctuated (Adamus et al., 1998a; Saito et al., 2007) . In addition, various leukocytes, including macrophages, CD4 + T cells, CD8 + T cells, and activated T suppressor cells were reported (Buchanan et al., 1984; Adamus et al., 1993; Solomon et al., 1999; Maeda et al., 2001; Penfold et al., 2001; Rong et al., 2002; Magrys et al., 2007; Ezzat et al., 2008; Morohoshi et al., 2009) . Mild chronic intraocular inflammation with a few vitreous cells, aqueous flare, cystoid macular edema, infiltration of macrophages, and accumulation of microglia were reported in different forms of retinal degeneration (Chen et al., 2002; Zipfel et al., 2010) . Waste products that accumulate in the retina, including drusen-containing complement factors, immunoglobulins, and pro-inflammatory cytokines/chemokines cause progressive loss of vision (Penfold et al., 2001; Ding et al., 2009; Xu et al., 2009) . During neurodegeneration, activated microglial cells participate in the phagocytosis of debris and facilitate regenerative processes. In addition, microglia activated by photoreceptor death kill adjacent cells (Gupta et al., 2003) . Therefore, they have dual functions in autoimmune retinal disease, including initiating inflammation of the retina and limiting subsequent inflammation (Chen et al., 2002) . Our laboratory has been interested in the pathogenic role of anti-retinal AAbs in retinal degenerative diseases. The past studies have shown that AAbs against retinal autoantigens such as recoverin, α-enolase and carbonic anhydrase II killed retinal cells in vitro, ex vivo, and in vivo (Adamus et al., 1998b; Ren and Adamus, 2004; Adamus and Karren, 2009) . Those AAbs can be detected at onset of retinal degeneration and can persist as the disease progresses. Thus, we proposed that AAbs not only can initiate, but can also contribute to the degenerative process. The objective of the current studies was to examine autoimmune responses over the course of retinopathy in the dystrophic RCS rat, a model for inherited retinal degeneration, and determine whether adoptive transfer of anti-retinal AAbs collected from dystrophic rats contributes to ongoing retinal degeneration in the recipient RCS rats. We selected the RCS rat model of retinal degeneration because of similar pathology to human inherited retinal degeneration. Moreover, autoimmunity has long been suspected to be a factor in RCS retinal degeneration but has not been explored (Chant and 
